Abstract: The present invention discloses and claims a compound of general formula (I) wherein A, X and R2 are as described herein. Also disclosed and claimed is application of this compound in a variety of therapeutic applications.

Abstract: Substituted 4-phenyl-2-aminothiazole derivatives, processes for preparing the same, and the use thereof as corticotrophin releasing factor (CRF) antagonists.

Abstract: The invention relates to a compound having general formula (I): Wherein R, R1, R2, X and n are as described herein. Also disclosed and claimed in certain of the embodiments herein are the methods of preparation of compound of formula (I) and its use in therapeutics.

Abstract: The present invention discloses and claims therapeutic use of a series of compounds of general formula (I) in which A, X and R2 are as described herein. Specifically, the compounds of formula (I) exhibit a particular activity as specific inhibitors of the glycine transporters glyt1 and/or glty2.

Abstract: This invention discloses and claims a compound of general formula (I) in which R1 represents either a hydrogen atom, or an optionally substituted alkyl group, or a cycloalkylalkyl group, or an optionally substituted phenylalkyl group, or an alkenyl group, X represents a hydrogen atom or one or more substituents chosen from halogen atoms and trifluoromethyl, alkyl and alkoxy groups, R2 represents one or more substituents chosen from halogen atoms, optionally substituted alkoxy and optionally substituted amino. The compounds of this invention exhibit therapeutic utility.

Abstract: This invention discloses and claims a compound of general formula (I) in which R1 represents either a hydrogen atom, or an optionally substituted alkyl group, or a cycloalkylalkyl group, or an optionally substituted phenylalkyl group, or an alkenyl group, X represents a hydrogen atom or one or more substituents chosen from halogen atoms and trifluoromethyl, alkyl and alkoxy groups, R2 represents one or more substituents chosen from halogen atoms, optionally substituted alkoxy and optionally substituted amino. The compounds of this invention exhibit therapeutic utility.

Abstract: The invention relates to a compound having general formula (I): Wherein R, R1, R2, X and n are as described herein. Also disclosed and claimed in certain of the embodiments herein are the methods of preparation of compound of formula (I)and its use in therapeutics.

Abstract: The present in relates to fabric enhancement compositions which provide reduced fabric abrasion damage.

Abstract: Compound of general formula (I) in which A represents either a group of formula N—R1 in which R1 represents a hydrogen atom, an alkyl group, a cycloalkyl group, a phenylalkyl group, an alkenyl group or an alkynyl group, or a group of formula N+(O?)R1 in which R1 is as defined above, or alternatively a group of formula N+(R?)R1 in which R? represents an alkyl group and R1 is as defined above, X represents a hydrogen atom or one or more substituents chosen from halogen atoms and trifluoromethyl, alkyl and alkoxy groups, R2 represents a hydrogen atom, one or more substituents chosen from halogen atoms and trifluoromethyl, alkyl and alkoxy groups, amino groups of formula NR3R4 in which R3 and R4 each represent a hydrogen atom or an alkyl group, or form with the nitrogen atom carrying them a pyrrolidine, piperidine or morpholine ring, or an optionally substituted phenyl group. Application in therapy.

Abstract: This invention discloses and claims a compound of general formula (I) in which R1 represents either a hydrogen atom, or an optionally substituted alkyl group, or a cycloalkylalkyl group, or an optionally substituted phenylalkyl group, or an alkenyl group, X represents a hydrogen atom or one or more substituents chosen from halogen atoms and trifluoromethyl, alkyl and alkoxy groups, R2 represents one or more substituents chosen from halogen atoms, optionally substituted alkoxy and optionally substituted amino. The compounds of this invention exhibit therapeutic utility.

Abstract: A liquid rinse-added fabric care composition that is characterized by at least two visually distinct phases when the composition is at rest and wherein at least one of the phases contains a fabric care agent is provided. The composition forms a temporary mixture when shaken that allows a consumer to dose a representative sample of the composition and spontaneously re-forms at least two visually distinct phases when allowed to remain at rest. The fabric care agents present in one or more phases of the composition may include fabric softener actives, color care agents, perfumes, antibacterial agents, malodor control agents, ultraviolet protection agents, anti-abrasion, anti-wear & fabric integrity agents, wrinkle control agents, and mixtures thereof. The composition should also contain less than about 5%, preferably less than about 3%, and even more preferably less than about 1% by weight of detergent actives.

Abstract: The present invention relates to novel branched substituted amino derivatives of 3-amino-1-phenyl-1H-[1,2,4]triazole, processes for their preparation and pharmaceutical compositions comprising them.

Abstract: The present in relates to fabric enhancement compositions which provide reduced fabric abrasion damage.

Abstract: A device for laying submarine pipeline from a vessel at sea. The device has a support or laying tower that can be inclined in a variable manner. The device has a workstation for assembling the successive parts of an offshore pipeline with the workstation attached to the vessel independently of the tower and is displaceable along the vessel to assemble the successive parts of the pipeline.

Abstract: The present invention relates to fabric enhancement compositions which provide reduced fabric abrasion damage. The compositions of the present invention comprise: a) one or more fabric abrasion polymers, said polymers comprising the following units: i) at least one monomeric unit comprising an amide moiety; ii) at least one monomeric unit comprising an N-oxide moiety; or iii) a polymer which contains at least one monomeric unit comprising an amide moiety and at least one monomeric unit comprising an N-oxide moiety; and b) the balance carriers and fabric conditioning or fabric enhancement ingredients.

Abstract: The present invention relates to the use of a softening compound having a transition temperature of less than 30° C. for providing good in-wear comfort.

Abstract: The present invention relates to compounds of formula: 1

Abstract: Substituted 4-phenyl-2-aminothiazole derivatives, processes for preparing the same, and the use thereof as corticotropin releasing factor (CRF) antagonists.

Abstract: The present invention relates to fabric care compositions which comprise low molecular weight linear or cyclic polyamines which provide the compositions with addition fabric enhancement benefits inter alia fabric softness, fabric integrity, fabric appearance, fabric lubricity.

Abstract: The present invention relates to fabric care and laundry detergent compositions which comprise low molecular weight modified and unmodified amines which provide enhanced fabric appearance benefits. The low molecular weight polyamines of the present invention which mitigate fabric damage and improve fabric appearance are preferably polypropyleneimines having three or four backbone amino units.